Class Action Lawsuit Filed Against Unicycive Therapeutics

A class action lawsuit was filed against Unicycive Therapeutics, Inc. in the United States District Court for the Northern District of California. The suit represents investors who purchased Unicycive securities between December 29, 2025, and June 29, 2026. The lawsuit alleges that Unicycive made false and misleading statements and failed to disclose material adverse facts. Specifically, the suit claims Unicycive had not inspected or audited its third-party manufacturing vendor’s facility compliance.

The lawsuit centers on allegations that Unicycive Therapeutics, Inc. provided misleading information regarding its manufacturing processes. If the allegations are substantiated, the company could face financial liabilities related to investor losses.